centuri
herald
emerg
two
novel
coronavirus
cov
unusu
high
pathogen
mortal
sever
acut
respiratori
syndrom
coronaviru
sarscov
first
identifi
initi
great
concern
sarscov
new
case
emerg
fund
research
decreas
howev
decad
later
middl
east
respiratori
syndrom
coronaviru
merscov
also
known
hcovemc
emerg
initi
saudi
arabia
sarscov
infect
peopl
result
death
approxim
infect
merscov
widespread
sarscov
appear
even
higher
mortal
rate
diagnos
infect
result
death
deadli
betacoronaviru
virus
exist
anim
reservoir
recent
cov
detect
anim
popul
rais
possibl
see
repeat
type
outbreak
near
futur
zoonot
virus
caus
much
sever
diseas
typic
seen
cov
make
global
health
concern
sarscov
merscov
result
sever
lung
patholog
mani
infect
patient
acut
lung
injuri
ali
condit
diagnos
base
presenc
pulmonari
edema
respiratori
failur
without
cardiac
caus
patient
progress
sever
form
ali
acut
respiratori
distress
syndrom
ard
order
surviv
given
infect
success
host
must
abl
clear
pathogen
toler
damag
caus
pathogen
also
host
immun
respons
refer
resili
abil
host
toler
effect
pathogen
immun
respons
pathogen
resili
host
abl
return
state
health
respond
infect
current
avail
treatment
option
infecti
diseas
antimicrobi
reprint
order
pleas
contact
reprint
futuremedicinecom
review
jamieson
futur
scienc
group
thu
target
pathogen
given
damag
pathogen
caus
focu
rapid
pathogen
clearanc
understand
howev
equal
import
medic
intervent
increas
abil
host
toler
direct
indirect
effect
pathogen
area
begin
explor
damag
lung
epithelium
respiratori
pathogen
common
caus
decreas
resili
review
explor
probabl
host
resili
pathway
viral
infect
particular
focu
emerg
coronavirus
also
examin
factor
make
patient
diseas
toler
patient
less
toler
viral
infect
factor
serv
guid
new
potenti
therapi
improv
patient
care
sarscov
merscov
typifi
rapid
progress
ard
howev
distinct
differ
infect
pathogen
two
virus
differ
receptor
lead
differ
cellular
tropism
sarscov
ubiquit
cell
type
speci
infect
sarscov
use
receptor
gain
entri
cell
merscov
use
ectopeptidas
unlik
sarscov
infect
caus
primarili
sever
respiratori
syndrom
merscov
infect
also
lead
kidney
failur
sarscov
also
spread
rapidli
host
merscov
easili
contain
unclear
due
affect
patient
popul
region
sinc
merscov
recent
discov
viru
research
done
sarscov
howev
given
similar
hope
find
also
appli
merscov
potenti
emerg
zoonot
coronavirus
viral
infect
elicit
strong
inflammatori
respons
also
abl
circumv
immun
respons
appear
sever
way
virus
evad
otherwis
redirect
immun
respons
pathway
lead
induct
antivir
type
interferon
ifn
respons
common
target
mani
virus
coronavirus
except
sarscov
merscov
contain
doubl
membran
vesicl
dmv
prevent
sens
genom
coronavirus
sever
viral
protein
suppress
type
ifn
respons
aspect
innat
antivir
immun
alter
type
ifn
respons
appear
play
role
immunopatholog
one
way
patient
high
initi
viral
titer
poor
prognosi
indic
reduct
antivir
respons
may
lead
direct
viralinduc
patholog
also
evid
delay
type
ifn
respons
lead
misregul
immun
respons
caus
immunopatholog
mous
model
sarscov
infect
type
ifn
respons
delay
delay
potent
antivir
respons
lead
decreas
viral
clearanc
time
increas
inflammatori
cell
immun
system
caus
excess
immunopatholog
case
delay
antivir
respons
caus
immunopatholog
also
fail
properli
control
viral
replic
research
need
appear
mer
similar
effect
innat
immun
respons
current
treatment
prevent
option
sarscov
merscov
limit
far
licens
vaccin
sarcov
merscov
although
sever
strategi
tri
anim
model
also
antivir
strategi
clearli
effect
control
trial
outbreak
sever
antivir
strategi
empir
tri
uncontrol
studi
gave
mix
result
main
antivir
use
ribavirin
lopinavir
ritonavir
often
use
combin
ifn
therapi
howev
retrospect
analysi
data
led
clear
conclus
efficaci
treatment
option
research
area
still
ongo
hope
soon
effect
strategi
treat
novel
cov
lack
effect
antivir
make
necessari
examin
potenti
treatment
sarscov
merscov
even
effect
strategi
decreas
viral
burden
virus
potenti
new
emerg
zoonot
cov
present
addit
complic
vaccin
produc
time
stop
spread
emerg
viru
addit
demonstr
sarscov
merscov
outbreak
alway
challeng
crisi
situat
know
host
resili
emerg
coronavirus
review
futur
scienc
group
wwwfuturemedicinecom
antivir
work
given
viru
one
method
address
develop
broadspectrum
antivir
target
conserv
featur
given
class
viru
howev
given
fast
mutat
rate
virus
sever
challeng
strategi
anoth
method
increas
abil
given
patient
toler
diseas
ie
target
host
resili
mechan
far
larg
form
support
care
reli
mechan
ventil
oxygen
sinc
sarscov
merscov
discov
rel
recent
lack
patient
experiment
data
howev
mani
virus
caus
ali
ard
includ
influenza
viru
iav
look
data
high
patholog
virus
extrapol
variou
pathway
could
target
infect
emerg
cov
add
understand
diseas
resili
mechan
learn
direct
studi
sarscov
merscov
increas
understand
host
resili
mechan
lead
futur
hostbas
therapi
could
increas
patient
surviv
one
common
theme
emerg
mani
respiratori
virus
includ
sarscov
merscov
much
patholog
due
excess
inflammatori
respons
studi
josset
et
al
examin
cell
host
respons
merscov
sarscov
discov
merscov
dysregul
host
transcriptom
much
greater
extent
sarscov
demonstr
glucocorticoid
may
potenti
way
alter
chang
host
transcriptom
late
time
point
infect
host
gene
respons
maintain
may
increas
diseas
resili
given
sever
diseas
manifest
sarscov
outbreak
mani
differ
treatment
option
empir
tri
human
patient
one
immunomodulatori
treatment
tri
sarscov
outbreak
system
corticosteroid
tri
without
use
type
ifn
therapi
could
directli
target
viru
retrospect
analysi
reveal
given
correct
time
appropri
patient
corticosteroid
use
could
decreas
mortal
also
length
hospit
stay
addit
evid
simultan
treatment
ifn
could
increas
potenti
benefit
although
treatment
without
complic
lack
random
control
trial
corticosteroid
broadli
immunosuppress
mani
physiolog
effect
sever
recent
studi
suggest
compound
could
use
increas
host
resili
viral
lung
infect
recent
paper
demonstr
topoisomeras
protect
inflammationinduc
death
varieti
viral
infect
includ
iav
blockad
complement
signal
also
suggest
possibl
option
decreas
inflamm
iav
infect
immunomodul
includ
celecoxib
mesalazin
eritoran
anoth
class
drug
suggest
statin
act
stabil
activ
aspect
innat
immun
respons
prevent
excess
inflamm
howev
decreas
immunopatholog
immunomodul
problemat
lead
increas
pathogen
burden
thu
increas
virusinduc
patholog
anoth
potenti
treatment
option
increas
tissu
repair
pathway
increas
host
resili
diseas
shown
bioinformat
well
sever
anim
model
therapi
shown
cell
cultur
model
system
anim
model
effect
demonstr
human
patient
correct
time
treatment
essenti
earli
intervent
shown
effect
case
therapi
work
better
given
slightli
later
cours
infect
onset
symptom
vari
slightli
patient
patient
need
precis
time
challeng
examin
potenti
treatment
option
sarscov
merscov
includ
consider
host
resili
addit
viral
effect
patholog
caus
immun
respons
variou
comorbid
associ
sarscov
merscov
lead
advers
outcom
interestingli
addit
risk
factor
lead
sever
diseas
differ
two
virus
unclear
differ
due
distinct
popul
affect
virus
properti
viru
understand
factor
could
key
increas
host
resili
infect
merscov
patient
increas
morbid
mortal
obes
immunocompromis
diabet
cardiac
diseas
review
jamieson
futur
scienc
group
risk
factor
sarscov
patient
includ
older
age
male
immun
factor
increas
mortal
sarscov
higher
neutrophil
count
low
tcell
count
one
factor
increas
diseas
patient
infect
sarscov
merscov
infect
virus
bacteria
similar
seen
mani
respiratori
infect
recent
studi
look
malaria
infect
anim
model
human
patient
demonstr
resili
host
predict
clinic
studi
start
correl
specif
biomark
diseas
outcom
ard
patient
understand
risk
factor
diseas
sever
perhap
predict
host
may
nonresili
tailor
treatment
option
appropri
clear
advantag
target
host
resili
pathway
therapi
use
treat
varieti
differ
infect
addit
need
develop
vaccin
understand
antivir
suscept
new
viru
toward
end
understand
patient
patient
popul
increas
suscept
paramount
import
addit
need
good
model
system
studi
respons
new
emerg
coronavirus
essenti
research
subject
lead
us
toward
improv
treatment
emerg
virus
caus
ali
sarscov
merscov
author
relev
affili
financi
involv
organ
entiti
financi
interest
financi
conflict
subject
matter
materi
discuss
manuscript
includ
employ
consult
honoraria
stock
ownership
option
expert
testimoni
grant
patent
receiv
pend
royalti
write
assist
util
product
manuscript
sever
acut
respiratori
syndrom
coronaviru
middl
east
respiratori
syndrom
coronaviru
zoonot
coronavirus
caus
acut
lung
injuri
acut
respiratori
distress
syndrom
antivir
limit
effect
cours
infect
coronavirus
current
vaccin
either
sever
acut
respiratori
syndrom
coronaviru
middl
east
respiratori
syndrom
coronaviru
host
resili
abil
host
toler
effect
infect
return
state
health
sever
pathway
includ
control
inflamm
metabol
tissu
repair
may
target
increas
host
resili
futur
challeng
target
host
resili
pathway
way
limit
effect
pathogen
clearanc
pathway
futur
studi
determin
safeti
type
treatment
human
patient
paper
special
note
highlight
